In last trading session, Precision Biosciences Inc (NASDAQ:DTIL) saw 0.36 million shares changing hands with its beta currently measuring 1.44. Company’s recent per share price level of $4.3 trading at $0.16 or 3.86% at ring of the bell on the day assigns it a market valuation of $47.68M. That closing price of DTIL’s stock is at a discount of -157.91% from its 52-week high price of $11.09 and is indicating a premium of 16.05% from its 52-week low price of $3.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.96 million shares which gives us an average trading volume of 258.03K if we extend that period to 3-months.
For Precision Biosciences Inc (DTIL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Precision Biosciences Inc (NASDAQ:DTIL) trade information
Upright in the green during last session for gaining 3.86%, in the last five days DTIL remained trading in the red while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $4.3 price level, adding 13.48% to its value on the day. Precision Biosciences Inc’s shares saw a change of -55.07% in year-to-date performance and have moved -10.23% in past 5-day. Precision Biosciences Inc (NASDAQ:DTIL) showed a performance of -13.48% in past 30-days. Number of shares sold short was 0.55 million shares which calculate 7.13 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15.5 to the stock, which implies a rise of 72.26% to its current value. Analysts have been projecting 1 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would jump 76.74% in reaching the projected high whereas dropping to the targeted low would mean a gain of 76.74% for stock’s current value.
Precision Biosciences Inc (NASDAQ:DTIL)’s Major holders
Insiders are in possession of 11.01% of company’s total shares while institution are holding 43.37 percent of that, with stock having share float percentage of 48.73%. Investors also watch the number of corporate investors in a company very closely, which is 43.37% institutions for Precision Biosciences Inc that are currently holding shares of the company. JANUS HENDERSON GROUP PLC is the top institutional holder at DTIL for having 0.63 million shares of worth $6.18 million. And as of 2024-06-30, it was holding 9.0879 of the company’s outstanding shares.
The second largest institutional holder is TANG CAPITAL MANAGEMENT LLC, which was holding about 0.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.9473 of outstanding shares, having a total worth of $6.07 million.
